ReviewPharmaceuticals (Basel, Switzerland)2026
Clinical Impact of Semaglutide Beyond Glycemic Control: A Critical Analysis of Oncogenic Potential and Mitigation of Cardiotoxicity.
Adriana Correra et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.